… marked uropathogenic strain of Escherichia coli, Nickel et al (85) established that biofilm …
to include other antibiotics and other organisms (JC Nickel & JW Costerton, unpublished …

… Curtis Nickel a , Leroy M Nyberg b , Mike Hennenfent c , for the INTERNATIONAL
PROSTATITIS COLLABORATIVE NETWORK … JC Nickel … JC Nickel, R. Sorensen …

… Dr Nickel reported serving as a consultant for GlaxoSmithKline, Pfizer, Watson, Farr Labs, …
Funding/Support: Dr Nickel's research in CP/CPPS is funded in part by the National Institute of …

To the Editor: We believe that due caution must be taken when interpreting the results of the
Fracture Intervention Trial II (FIT-II), 1 since the conclusion appears to be based on post hoc …

Purpose : Chronic abacterial prostatitis is a syndrome characterized by pelvic pain and
voiding symptoms, which is poorly defined, poorly understood, poorly treated and bothersome. …

Background Finasteride is known to improve urinary symptoms in men with benign prostatic
hyperplasia, but the extent to which the benefit is sustained and whether finasteride reduces …

When disks of urinary catheter material were exposed to the flow of artificial urine containing
cells of Pseudomonas aeruginosa, a thick adherent biofilm, composed of these bacteria …

Objectives. To study the efficacy and safety of dutasteride, a dual inhibitor of the 5-alpha-reductase
isoenzymes types I and II. Methods. A total of 4325 men (2951 completed) with …

… and penile discomfort, and measurement of prostatitis-like symptoms that investigators based
on the previously published and partially validated prostatitis symptom score of Nickel and …

OBJECTIVE: The ongoing REDUCE trial is a 4-yr, phase 3, placebo-controlled study to
determine if daily dutasteride 0.5mg reduces the risk of biopsy detectable prostate cancer. …